 
MAINE STATE LEGISLATURE 
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY 
at the Maine State Law and Legislative Reference Library 
http://legislature.maine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting differences from printed original) 
 
 
Printed on recycled paper
131st MAINE LEGISLATURE
SECOND REGULAR SESSION-2024
Legislative Document No. 2139
H.P. 1363 House of Representatives, January 3, 2024
An Act to Add Schedule V Substances to the Controlled Substances 
Prescription Monitoring Program
Submitted by the Department of Health and Human Services pursuant to Joint Rule 203.
Reference to the Committee on Health and Human Services suggested and ordered printed.
ROBERT B. HUNT
Clerk
Presented by Representative MEYER of Eliot.

Page 1 - 131LR2765(01)
1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA ยง7246, sub-ยง1, as enacted by PL 2003, c. 483, ยง1, is amended to 
3 read:
41.  Controlled substance.  "Controlled substance" means a controlled substance 
5 included in schedules II, III or , IV or V of 21 United States Code, Section 812 or 21 Code 
6 of Federal Regulations, Section 1308.
7SUMMARY
8 This bill expands the required reporting on controlled substances under the Controlled 
9 Substances Prescription Monitoring Program to include drugs, substances and chemicals 
10 listed in the federally determined Schedule V.  Schedule V drugs, substances and chemicals 
11 consist of preparations containing limited quantities of certain narcotics and are generally 
12 used for antidiarrheal, antitussive and analgesic purposes.
8
9
10
11
12
